Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Timothy M Miller

Showing results (101-110 of 128) with videos related to

Pageof 13
Sort By:
Neuron|May 18, 2018
Tau Kinetics in Neurons and the Human Central Nervous SystemChihiro Sato, Nicolas R Barthélemy, Kwasi G Mawuenyega, et al.
The Lancet. Neurology|April 2, 2013
An antisense oligonucleotide against SOD1 delivered intrathecally for patients with SOD1 familial amyotrophic lateral sclerosis: a phase 1, randomised, first-in-man studyTimothy M Miller, Alan Pestronk, William David, et al.
Annals of Neurology|June 20, 2017
Phosphorylated neurofilament heavy chain: A biomarker of survival for C9ORF72-associated amyotrophic lateral sclerosisTania F Gendron, , Lillian M Daughrity, et al.
Science Advances|November 5, 2021
TSC1 loss increases risk for tauopathy by inducing tau acetylation and preventing tau clearance via chaperone-mediated autophagyCarolina Alquezar, Kathleen M Schoch, Ethan G Geier, et al.
Nature Reviews. Neurology|June 22, 2019
SILK studies - capturing the turnover of proteins linked to neurodegenerative diseasesRoss W Paterson, Audrey Gabelle, Brendan P Lucey, et al.
The Journal of Clinical Investigation|July 17, 2018
Antisense oligonucleotides extend survival and reverse decrement in muscle response in ALS modelsAlex McCampbell, Tracy Cole, Amy J Wegener, et al.
Biorxiv : the Preprint Server for Biology|January 30, 2023
A DUAL MTOR/NAD+ ACTING GEROTHERAPYJinmei Li, Sandeep Kumar, Kirill Miachin, et al.
The New England Journal of Medicine|September 21, 2022
Trial of Antisense Oligonucleotide Tofersen for <i>SOD1</i> ALSTimothy M Miller, Merit E Cudkowicz, Angela Genge, et al.
Biorxiv : the Preprint Server for Biology|June 25, 2024
Lipid-siRNA conjugate accesses perivascular transport and achieves durable knockdown throughout the central nervous systemAlexander G Sorets, Katrina R Schwensen, Nora Francini, et al.
Science Translational Medicine|November 12, 2020
Plasma neurofilament light predicts mortality in patients with strokeTania F Gendron, Mohammed K Badi, Michael G Heckman, et al.
Pageof 13

Showing results (101-110 of 128) with videos related to

Sort By:
Pageof 13
Neuron|May 18, 2018
Tau Kinetics in Neurons and the Human Central Nervous SystemChihiro Sato, Nicolas R Barthélemy, Kwasi G Mawuenyega, et al.
The Lancet. Neurology|April 2, 2013
An antisense oligonucleotide against SOD1 delivered intrathecally for patients with SOD1 familial amyotrophic lateral sclerosis: a phase 1, randomised, first-in-man studyTimothy M Miller, Alan Pestronk, William David, et al.
Annals of Neurology|June 20, 2017
Phosphorylated neurofilament heavy chain: A biomarker of survival for C9ORF72-associated amyotrophic lateral sclerosisTania F Gendron, , Lillian M Daughrity, et al.
Science Advances|November 5, 2021
TSC1 loss increases risk for tauopathy by inducing tau acetylation and preventing tau clearance via chaperone-mediated autophagyCarolina Alquezar, Kathleen M Schoch, Ethan G Geier, et al.
Nature Reviews. Neurology|June 22, 2019
SILK studies - capturing the turnover of proteins linked to neurodegenerative diseasesRoss W Paterson, Audrey Gabelle, Brendan P Lucey, et al.
The Journal of Clinical Investigation|July 17, 2018
Antisense oligonucleotides extend survival and reverse decrement in muscle response in ALS modelsAlex McCampbell, Tracy Cole, Amy J Wegener, et al.
Biorxiv : the Preprint Server for Biology|January 30, 2023
A DUAL MTOR/NAD+ ACTING GEROTHERAPYJinmei Li, Sandeep Kumar, Kirill Miachin, et al.
The New England Journal of Medicine|September 21, 2022
Trial of Antisense Oligonucleotide Tofersen for <i>SOD1</i> ALSTimothy M Miller, Merit E Cudkowicz, Angela Genge, et al.
Biorxiv : the Preprint Server for Biology|June 25, 2024
Lipid-siRNA conjugate accesses perivascular transport and achieves durable knockdown throughout the central nervous systemAlexander G Sorets, Katrina R Schwensen, Nora Francini, et al.
Science Translational Medicine|November 12, 2020
Plasma neurofilament light predicts mortality in patients with strokeTania F Gendron, Mohammed K Badi, Michael G Heckman, et al.
Pageof 13